Extension of a research agreement with Galapagos

Lyon ‐ February 18^th, 2020

Building upon the positive results of an ongoing research collaboration aimed at the production of jointly designed chemical libraries, Edelris and Galapagos announce today that they have agreed to extend their multi‐year partnership.

Jean‐Yves Ortholand, CEO of Edelris, said “The decision from Galapagos to extend such a successful and multi‐faceted collaboration is a great recognition of our client‐oriented mindset and the dedication of our teams to successfully reaching the predefined objectives. We certainly look forward to delivering many additional innovative compounds with unique and very specific modalities, to support Galapagos in their screening efforts.”

“In order to address innovative and difficult biological targets, Galapagos has recognized the need for increased chemical space coverage as well as novel and biorelevant chemical matter. Edelris, through its proven track record, high‐level creativity and cutting‐edge technologies such as flow‐ photochemistry, has been the ideal partner towards this goal.” added Didier Roche, CSO of Edelris. Other terms of the collaboration, including scientific, technical and financial, were not disclosed.

Download

More news

{"acf_fc_layout":"postList","postList_model":{"ID":3651,"post_author":"5","post_date":"2023-09-05 09:18:27","post_date_gmt":"2023-09-05 07:18:27","post_content":"","post_title":"More news","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"more-news","to_ping":"","pinged":"","post_modified":"2023-11-20 08:54:07","post_modified_gmt":"2023-11-20 07:54:07","post_content_filtered":"","post_parent":0,"guid":"https:\/\/www.edelris.com\/?post_type=waz_post_template&p=3651","menu_order":38,"post_type":"waz_post_template","post_mime_type":"","comment_count":"0","filter":"raw"},"postList_post_type":"actualites","postList_category_post":false,"postList_category_actualites":false,"postList_nb_item_per_line":"postList_2_item","postList_nb_max_item":"2","postList_order_by":"none","postList_order_date_which":"acf","postList_order_date_elements":"future","postList_order_date_ordering":"ASC","postList_set_link":true,"postList_link_waz_popup":true,"postList_category_navigation":false,"postList_rub_nav_dropdown":false,"postList_rub_nav_position":"left","postList_rub_nav_all":"Tous les articles","postList_pagination":false,"postList_pagination_nb_posts":12,"postList_pagination_btn_model":false,"postList_pagination_text":"","options":{"animation":false,"animation_delay":0,"animation_element_delay":100,"margin_bottom":"","postList_id":""},"postList_limit_title":"","postList_limit_subtitle":"","postList_limit_description":"","postList_limit_break":"word","postList_limit_add_to_end":"","postList_use_custom_post_type":false,"postList_custom_post_type":"","postList_custom_taxonomy":"","postList_custom_toxonomy_values":"","postList_custom_title":"","postList_custom_subtitle":"","postList_custom_description":"","postList_custom_date":""}

About Edelris

Expanding the boundaries for your small molecule drug discovery!

Edelris is a leading Drug Discovery CRO, providing Compound Libraries, Organic & Medicinal Chemistry, High Throughput Screening, and Analytical expert services to the Pharmaceutical, Cosmetic, Crop Protection, and Biotech sectors.

Cross-fertilizing our combined experiences, knowledge, and techniques, together we break through to successful solutions for you.